An Inhibitory Effect of MAD1 on Bladder Tumor Cellular Proliferation in Vivo

References

1. ↵
   1. Bowles L,
   2. Bialkowska-Hobrzanska H,
   3. Bukala B, et al

   . A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer. Can J Urol. 2004;1:2438–2344.

   OpenUrl
2. ↵
   1. Sanchini MA,
   2. Bravaccini S,
   3. Medri L, et al

   . Urine telomerase: an important marker in the diagnosis of bladder cancer. Neoplasia. 2004;6:234–239.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Nair SK,
   2. Burley SK

   . X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell. 2003;112:193–205.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Luscher B,
   2. Larsson LG

   . The basic region/helix-loop-helix/leucine zipper domain of Myc proto -oncoproteins: function and regulation. Oncogene. 1999;18:2955–2566.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Ayer DE,
   2. Eisenman RN

   . A switch from Myc:Max to Mad: Max heterocomplexes accompanies monocyte/ macrophage differentiation. Genes Dev. 1993;7:2110–2119.

   OpenUrlAbstract/FREE Full Text
6. ↵
   1. Queva C,
   2. Hurlin PJ,
   3. Foley KP, et al

   . Sequential expression of the MAD family of trans criptional repressors during differentiation and development. Oncogene. 1998;16:967–977.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Zou L,
   2. Zhang PH,
   3. Luo CL, et al

   . Transcript regulation of human telomerase reverse transcriptase by c -myc and madl. Acta Biochim Biophys Sin. 2005;37:32–38.

   OpenUrl
8. ↵
   1. Steinberg GD,
   2. Brendler CB,
   3. Squire RA, et al

   . Experimental intravesical therapy for superficial transitional cell carcinoma in a rat bladder tumor model. J Urol. 1991;145:647–653.

   OpenUrlPubMed
9. ↵
   1. Harrington L,
   2. Zhou W,
   3. McPhail T, et al

   . Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 1997;11:3109–3115.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Counter CM,
    2. Meyerson M,
    3. Eaton EN, et al

    . Telomerase activity is restored in hum an cells by ectopic expression of Htert (bEST2), the catalytic subunit of telomerase. Oncogene. 1998;16:1217–1222.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Ito H,
    2. Kyo S,
    3. Kanaya T, et al

    . Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res. 1998;4:1603–1608.

    OpenUrlAbstract
12. ↵
    1. De Kok JB,
    2. Schalken JA,
    3. Aalders TW, et al

    . Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas. Int J Cancer. 2000;87:217–220.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Nikiforov MA,
    2. Popov N,
    3. Kotenko I, et al

    . The Mad and Myc basic domains are functionally equivalent. J Biol Chem. 2003;278:11094–11099.

    OpenUrlAbstract/FREE Full Text
14. ↵
    1. Xu D,
    2. Popov N,
    3. Hou M, et al

    . Switch from Myc/Max to Madl/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sei USA. 2001;98:3826–3831.

    OpenUrl
15. ↵
    1. McMahon SB,
    2. Wood MA,
    3. Cole MD, et al

    . The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol. 2000;20:556–562.

    OpenUrlAbstract/FREE Full Text
16. ↵
    1. Alland L,
    2. David G,
    3. Shen-Li H, et al

    . Identification of mammalian Sds3 as an integral component of the Sin3/histone deacetylase corepressor complex. Mol Cell Biol. 2002;22:2743–2750.

    OpenUrlAbstract/FREE Full Text
17. ↵
    1. Gandarillas A.

    Epidermal differentiation, apoptosis, and senescence: common pathways? Exp Gerontol. 2000;35:53–62.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    1. Walkley CR,
    2. Fero ML,
    3. Chien WM, et al

    . Negative cellcycle regulators cooperatively control self -renewal and differentiation of haematopoietic stem cells. Natu Cell Biol. 2005;7:172–178.

    OpenUrl
19. ↵
    1. Sumi M,
    2. Tauchi T,
    3. Sashida G, et al

    . A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia. Int J Oncol. 2004;24:1481–1487.

    OpenUrlPubMedWeb of Science
20. ↵
    1. Indes CM,
    2. Schultes CM,
    3. Kelland LR, et al

    . Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up -regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor. Mol Pharmacol. 2003;64:1101–1108.

    OpenUrl